Consensus $38.4M. Reiterating full year 2025 gross margin guidance of 61% – 63%. Reiterating positive cash flow from operations for full year 2025.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
- Koru Medical management to meet with Craig-Hallum
- KORU Medical’s CCO Resigns, Interim Leader Appointed
- Repro-Med Systems’ Earnings Call Highlights Growth and Challenges
- REPRO-MED Systems: Strong Financial Performance and Strategic Growth Justify Buy Rating
- KORU Medical Systems Reports Record 2024 Financial Results